lvrachЛечащий ВрачLechaschi Vrach1560-51752687-1181ООО «Издательство "Открытые системы"»10.26295/OS.2020.77.98.001lvrach-160Research ArticleСтатьиФибромиалгия как междисциплинарная проблема - возможности и перспективы диагностики и леченияFibromyalgia as an interdisciplinary problem — the possibilities and prospects of diagnosis and treatmentКолоколовО. В.KolokolovO. V.

доктор медицинских наук,

Саратов

Doctor of Medicine,

Saratov

kolokolov@inbox.ruСалинаЕ. А.SalinaE. A.

кандидат медицинских наук,

Саратов

PhD in Medicine,

Saratov 

noemail@neicon.ruКолоколоваТ. О.KolokolovaT. O.

Москва

Moscow 

noemail@neicon.ruЛукинаЕ. В.LukinaE. V.

кандидат медицинских наук,

Саратов

PhD in Medicine,

Saratov 

noemail@neicon.ruСиткалиИ. В.SitkaliI. V.

Саратов

Saratov

noemail@neicon.ruФГБОУ ВО Саратовский ГМУ им. В. И. Разумовского МРРоссияSaratov State Medical University named after V. I. RazumovskyRussian FederationФГБОУ ВО МГППУРоссияMoscow State University of Psychology and Education (MSUPE)Russian Federation202023062021073641Copyright © Колоколов О.В., Салина Е.А., Колоколова Т.О., Лукина Е.В., Ситкали И.В., 20212021Колоколов О.В., Салина Е.А., Колоколова Т.О., Лукина Е.В., Ситкали И.В.Kolokolov O.V., Salina E.A., Kolokolova T.O., Lukina E.V., Sitkali I.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.lvrach.ru/jour/article/view/160

В статье обсуждается фибромиалгия (ФМ) как актуальная междисциплинарная проблема. С позиции современной медицины ФМ рассматривают как хроническое заболевание, характеризующееся распространенной персистирующей скелетно-мышечной болью невоспалительного характера, которую сопровождают усталость, нарушение сна и когнитивные расстройства. Авторами сделан акцент на обзоре литературы об этиологии ФМ, которая является мультифакториальным заболеванием в частности, в его развитии большое значение имеет генетическая предрасположенность и состояние микробиоты кишечника. Необходимо широко использовать критерии клинической диагностики ФМ диагноз может быть установлен в условиях учреждений, оказывающих первичную медико-санитарную помощь, на основании оценки соответствия критериям Американской коллегии ревматологов (The American College of Rheumatology, ACR) 2016 г. и при условии нормальных результатов объективного осмотра и лабораторных тестов, исключающих другие заболевания. Авторы обращают внимание на значимость комплексного подхода (фармакотерапия, физическая реабилитация, психотерапия) в лечении ФМ представлена точка зрения врачей и психологов.

The article discusses fibromyalgia (FM) as a topical interdisciplinary problem. From the point of view of modern medicine, FM is considered a chronic disease characterized by widespread persistent musculoskeletal pain of a non-inflammatory nature, which is accompanied by fatigue, sleep disturbances and cognitive impairments. The authors focused on a review of the literature on the etiology of FM, which is a multifactorial disease — in particular, genetic predisposition and the state of the intestinal microbiota are of great importance in its development. The criteria for clinical diagnosis of FM should be widely used — the diagnosis can be made in primary health care settings based on the assessment of compliance with the criteria of The American College of Rheumatology (ACR, 2016) and subject to normal results of physical examination and laboratory tests, excluding other diseases. The authors draw attention to the importance of an integrated approach (pharmacotherapy, physical rehabilitation, psychotherapy) in the treatment of FM — the point of view of doctors and psychologists is presented. 

PremiumБолевой синдромГенетический полиморфизмМикробиота кишечникаПсихологияПсихотерапияРевматологияФибромиалгияФизическая реабилитацияХроническая больpainchronic painfibromyalgiagenetic polymorphismintestinal microbiotaphysical rehabilitationpsychologypsychotherapyReferencesWolfe F., Smythe H. A., Yunus M. B. et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee // Arthritis Rheum. 1990; 33 (2): 160–172.Wolfe F., Smythe H. A., Yunus M. B. et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee // Arthritis Rheum. 1990; 33 (2): 160–172.Wolfe F., Clauw D. J., Fitzcharles M. A. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity // Arthritis Care Res (Hoboken). 2010; 62 (5): 600–610.Wolfe F., Clauw D. J., Fitzcharles M. A. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity // Arthritis Care Res (Hoboken). 2010; 62 (5): 600–610.Wolfe F., Clauw D. J., Fitzcharles M. A. et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia // J Rheumatol. 2011; 38 (6): 1113–1122.Wolfe F., Clauw D. J., Fitzcharles M. A. et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia // J Rheumatol. 2011; 38 (6): 1113–1122.Wolfe F., Clauw D. J., Fitzcharles M. A., et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria // Semin Arthritis Rheum. 2016; 46 (3): 319–329.Wolfe F., Clauw D. J., Fitzcharles M. A., et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria // Semin Arthritis Rheum. 2016; 46 (3): 319–329.Колоколов О. В., Колоколова А. М, Ситкали И. В. Фибромиалгия: новое о международных критериях диагностики и тактики ведения пациентов // Терапия. 2017; № 5 (15): 94–104.Kolokolov O.V., Kolokolova A.M, Sitkali I.V. Fibromialgiya: novoye o mezhdunarodnykh kriteriyakh diagnostiki i taktiki vedeniya patsiyentov [Fibromyalgia: new about international diagnostic criteria and patient management tactics] Terapiya. 2017; №5 (15): pp 94–104.Колоколов О. В., Ситкали И. В., Шахпазов С. Ж., Колоколова А. М. Синдром хронической распространенной боли — новая междисциплинарная проблема или компетенция врача общей практики? // Фарматека. 2018; № 5: 71–80.Kolokolov O.V., Sitkali I.V., Shakhpazov S.Zh., Kolokolova A.M Sindrom khronicheskoy rasprostranennoy boli — novaya mezhdistsiplinarnaya problema ili kompetentsiya vracha obshchey praktiki? [Chronic pain syndrome — a new interdisciplinary problem or the competence of a general practitioner?] Farmateka. 2018; №5: pp 71–80.Häuser W., Ablin J., Fitzcharles M. A. et al. Fibromyalgia // Nat Rev Dis Primers. 2015; 1: 15022.Häuser W., Ablin J., Fitzcharles M. A. et al. Fibromyalgia // Nat Rev Dis Primers. 2015; 1: 15022.Jakobsson U. The epidemiology of chronic pain in a general population: results of a survey in southern Sweden // Scand J Rheumatol. 2010; 39: 421–429.Jakobsson U. The epidemiology of chronic pain in a general population: results of a survey in southern Sweden // Scand J Rheumatol. 2010; 39: 421–429.Jones G. T., Atzeni F., Beasley M. et al. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria // Arthritis Rheumatol. 2015; 67: 568–575.Jones G. T., Atzeni F., Beasley M. et al. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria // Arthritis Rheumatol. 2015; 67: 568–575.Mansfield K. E., Sim J., Jordan J. L., Jordan K. P. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population // Pain. 2016; 157 (1): 55–64.Mansfield K. E., Sim J., Jordan J. L., Jordan K. P. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population // Pain. 2016; 157 (1): 55–64.Marques A. P., Santo A. S., Berssaneti A. A. et al. Prevalence of fibromyalgia: literature review update // Rev Bras Reumatol Engl Ed. 2017; 57 (4): 356–363.Marques A. P., Santo A. S., Berssaneti A. A. et al. Prevalence of fibromyalgia: literature review update // Rev Bras Reumatol Engl Ed. 2017; 57 (4): 356–363.Waylonis G. W., Heck W. Fibromyalgia syndrome. New associations // Am J Phys Med Rehabil. 1992; 71: 343–348.Waylonis G. W., Heck W. Fibromyalgia syndrome. New associations // Am J Phys Med Rehabil. 1992; 71: 343–348.Galvez-Sánchez C. M., Reyes Del Paso G. A. Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives // J Clin Med. 2020; 9 (4): 1219.Galvez-Sánchez C. M., Reyes Del Paso G. A. Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives // J Clin Med. 2020; 9 (4): 1219.Buskila D., Sarzi-Puttini P. Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome // Arthritis Research & Therapy. 2006; 8 (5): 218.Buskila D., Sarzi-Puttini P. Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome // Arthritis Research & Therapy. 2006; 8 (5): 218.Park D.-J., Lee S.-S. New insights into the genetics of fibromyalgia // The Korean journal of internal medicine. 2017; 32 (6): 984–995.Park D.-J., Lee S.-S. New insights into the genetics of fibromyalgia // The Korean journal of internal medicine. 2017; 32 (6): 984–995.D’Agnelli S., Arendt-Nielsen L., Gerra M. C. et al. Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers // Molecular Pain. 2019; 15: 1–12.D’Agnelli S., Arendt-Nielsen L., Gerra M. C. et al. Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers // Molecular Pain. 2019; 15: 1–12.Feng J., Zhang Z., Wu X. et al. Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencing // PLoS One. 2013; 8: e65033.Feng J., Zhang Z., Wu X. et al. Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencing // PLoS One. 2013; 8: e65033.Docampo E., Escaramis G., Gratacos M. et al. Genome-wide analysis of single nucleotide polymorphisms and copy number variants in fibromyalgia suggest a role for the central nervous system // Pain. 2014; 155 (6): 1102–1109.Docampo E., Escaramis G., Gratacos M. et al. Genome-wide analysis of single nucleotide polymorphisms and copy number variants in fibromyalgia suggest a role for the central nervous system // Pain. 2014; 155 (6): 1102–1109.Kim S.-K., Kim S.-H., Nah S.-S. et al. Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population // J Rheumatol. 2013; 40 (3): 316–322.Kim S.-K., Kim S.-H., Nah S.-S. et al. Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population // J Rheumatol. 2013; 40 (3): 316–322.Murphy Jr. G. M., Sarginson J. E., Ryan H. S. et al. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression // Pharmacogenet Genomics. 2013; 23 (6): 301–313.Murphy Jr. G. M., Sarginson J. E., Ryan H. S. et al. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression // Pharmacogenet Genomics. 2013; 23 (6): 301–313.Sarchielli P., Mancini M. L., Floridi A. et al. Increased levels of neurotrophins are not specifc for chronic migraine: evidence from primary fbromyalgia syndrome // J Pain. 2007; 8 (9): 737–745.Sarchielli P., Mancini M. L., Floridi A. et al. Increased levels of neurotrophins are not specifc for chronic migraine: evidence from primary fbromyalgia syndrome // J Pain. 2007; 8 (9): 737–745.

The authors declare that there are no conflicts of interest present.